The leading contenders in Alzheimer’s drugs
May 21, 2021
2 minutes
Among the larger biotechnology and pharmaceutical firms, stands out for putting a lot of resources into finding an effective treatment for Alzheimer’s. Even if the FDA’s decision on whether to approve aducanumab, which is due in June, ends up going against it, Biogen has four other Alzheimer’s treatments
You’re reading a preview, subscribe to read more.
Start your free 30 days